Cargando…
Influenza antivirals currently in late‐phase clinical trial
Influenza antiviral drugs are important for the control of influenza, most specifically for the treatment of influenza patients with severe disease following infection with a seasonal influenza virus, a newly emerging influenza strain, or in the event of a pandemic. Many influenza antivirals that ar...
Autores principales: | Koszalka, Paulina, Tilmanis, Danielle, Hurt, Aeron C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410715/ https://www.ncbi.nlm.nih.gov/pubmed/28146320 http://dx.doi.org/10.1111/irv.12446 |
Ejemplares similares
-
Antiviral Therapy for the Next Influenza Pandemic
por: Hurt, Aeron C.
Publicado: (2019) -
Highlights from Heart Rhythm 2018: Late-breaking Clinical Trial Considerations
por: Olshansky, Brian
Publicado: (2018) -
Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model
por: Koszalka, Paulina, et al.
Publicado: (2022) -
A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions
por: Koszalka, Paulina, et al.
Publicado: (2020) -
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
por: Broadbent, Lindsay, et al.
Publicado: (2015)